Form 4 for PYXS Pyxis Oncology, Inc.
Accepted 2023-03-28 00:00:00 ET · period of report 2023-03-24 · accession 0001209191-23-021407 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-03-28 | 2023-03-24 | PYXS | FLAVIN JOHN L | Dir | A - Grant | $0.00 | +139.4K | 377.8K | +58% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-03-24 | A | A | 139,355 | $0.00 | 377,796 | D | — | — | (F1) Represents restricted stock units that vest 100% on the first anniversary of the grant date, subject to the reporting person's continued service through the applicable vesting date. |